iPS-Derived Heart Muscle Transplant Improves Cardiac Functions
Tokyo, Dec. 13 (Jiji Press)–A clinical trial by a Tokyo-based venture company originating from Keio University has confirmed that transplanting cardiac muscle cell clusters called cardiomyocyte spheroids created from induced pluripotent stem, or iPS, cells into patients with severe heart failure improved